Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-14

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for atorvastatin calcium from NorthStar RxLLC, authorizing a generic version of atorvastatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)